Age-related change of serum angiogenic factor levels in patients with coronary artery disease

Acta Cardiologica

Volumn 64, Issue 6, 2009, Pages 735-740

  Meng, Rongsen ^a,b   Pei, Zhaohui ^a   Chen, Bo ^c   Ma, Rui ^a   Zhang, Chengxi ^a   Chen, Baolin ^a   Zhang, Aixia ^a   Wu, Tongguo ^b   Liu, Dan ^a   Dong, Yugang ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU RED CROSS HOSPITAL   (China)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Age; Angiopoietins; Coronary artery disease; Vascular endothelial growth factors

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; REGRESSION ANALYSIS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANGIOPOIETIN-1; ANGIOPOIETIN-2; CORONARY ARTERY DISEASE; FEMALE; HUMANS; LINEAR MODELS; MIDDLE AGED; PROGNOSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 74749093363     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.64.6.2044736     Document Type: Article

References (23)

1. Shurin GV, Yurkovetsky ZR, Chatta GS, Tourkova IL, Shurin MR, Lokshin AE. Dynamic alteration of soluble serum biomarkers in healthy aging. Cytokine 2007; 39: 123-9.
2. Habib GB, Heibig J, Forman SA, Brown BG, Roberts R, Terrin ML, Bolli R. Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators. Circulation 1991; 83: 739-46.
3. Nathoe HM, Koerselman J, Buskens E, van Dijk D, Stella PR, Plokker TH, Doevendans PA, Grobbee DE, de Jaegere PP. Determinants and prognostic significance of collaterals in patients undergoing coronary revascularization. Am J Cardiol 2006; 98: 31-5.
4. Graham MM, Ghali WA, Faris PD, Galbraith PD, Norris CM, Knudtson ML. Survival after coronary revascularization in the elderly. Circulation 2002; 105: 2378-84.
5. Balasch J, Guimera M, Martinez-Pasarell O, Ros J, Vanrell JA, Jimenez W. Adrenomedullin and vascular endothelial growth factor production by follicular fluid macrophages and granulosa cells. Hum Reprod 2004; 19: 808-14.
6. Hubbard NE, Lim D, Mukutmoni M, Cai A, Erickson KL. Expression and regulation of murine macrophage angiopoietin-2. Cell Immunol 2005; 234: 102-9.
7. Martin D, Galisteo R, Gutkind JS. CXCL8/IL8 stimulates vascular endothelial growth factor (VEGF) expression and the autocrine activation of VEGFR2 in endothelial cells by activating NFkappaB through the CBM (Carma3/Bcl10/Malt1) complex. J Biol Chem 2009; 284: 6038-42.
8. Hangai M, He S, Hoffmann S, Lim JI, Ryan SJ, Hinton DR. Sequential induction of angiogenic growth factors by TNF-alpha in choroidal endothelial cells. J Neuroimmunol 2006; 171: 45-56.
9. Gon Y, Hashimoto S, Hayashi S, Koura T, Matsumoto K, Horie T. Lower serum concentrations of cytokines in elderly patients with pneumonia and the impaired production of cytokines by peripheral blood monocytes in the elderly. Clin Exp Immunol 1996; 106: 120-6.
10. Matz RL, Andriantsitohaina R. Age-related endothelial dysfunction: Potential implications for pharmacotherapy. Drugs Aging 2003; 20: 527-50.
11. Brandes RP, Fleming I, Busse R. Endothelial aging. Cardiovasc Res 2005; 66: 286-94.
12. Liou JY, Shyu KG, Lu MJ, Chao HH, Wang BW, Kuan PL. Pericardial fluid and serum levels of vascular endothelial growth factor and endostatin in patients with or without coronary artery disease. J Formos Med Assoc 2006; 105: 377-83.
13. Lee KW, Lip GY, Blann AD. Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes. Circulation 2004; 110: 2355-60.
14. Kucukardali Y, Aydogdu S, Ozmen N, Yonem A, Solmazgul E, Ozyurt M, Cingozbay Y, Aydogdu A. The relationship between severity of coronary artery disease and plasma level of vascular endothelial growth factor. Cardiovasc Revasc Med 2008; 9: 66-70.
15. Swift ME, Kleinman HK, DiPietro LA. Impaired wound repair and delayed angiogenesis in aged mice. Lab Invest 1999; 79: 1479-87.
16. Setoguchi S, Glynn RJ, Avorn J, Mittleman MA, Levin R, Winkelmayer WC. Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: A 10-year trend analysis. J Am Coll Cardiol 2008; 51: 1247-54.
17. Kaplan RC, Heckbert SR, Furberg CD, Psaty BM. Predictors of subsequent coronary events, stroke, and death among survivors of first hospitalized myocardial infarction. J Clin Epidemiol 2002; 55: 654-64.
18. Berry C, Balachandran KP, L'Allier PL, Lesperance J, Bonan R, Oldroyd KG. Importance of collateral circulation in coronary heart disease. Eur Heart J 2007; 28: 278-91.
19. Benndorf RA, Schwedhelm E, Gnann A, Taheri R, Kom G, Didie M, Steenpass A, Ergun S, Boger RH. Isoprostanes inhibit vascular endothelial growth factor-induced endothelial cell migration, tube formation, and cardiac vessel sprouting in vitro, as well as angiogenesis in vivo via activation of the thromboxane A(2) receptor: A potential link between oxidative stress and impaired angiogenesis. Circ Res 2008; 103: 1037-46.
20. Werner GS, Jandt E, Krack A, Schwarz G, Mutschke O, Kuethe F, Ferrari M, Figulla HR. Growth factors in the collateral circulation of chronic total coronary occlusions: Relation to duration of occlusion and collateral function. Circulation 2004; 110: 1940-5.
21. Fleisch M, Billinger M, Eberli FR, Garachemani AR, Meier B, Seiler C. Physiologically assessed coronary collateral flow and intracoronary growth factor concentrations in patients with 1- to 3-vessel coronary artery disease. Circulation 1999; 100: 1945-50.
22. Asahara T, Chen D, Takahashi T, Fujikawa K, Kearney M, Magner M, Yancopoulos GD, Isner JM. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res 1998; 83: 233-40.
23. Jaumdally RJ, Varma C, Blann AD, MacFadyen RJ, Lip GY. Systemic and intracardiac vascular endothelial growth factor and angiopoietin-1 and -2 levels in coronary artery disease: Effects of angioplasty. Ann Med 2007; 39: 298-305.